Researchers test mRNA technology for universal flu vaccine
An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.
The two-dose vaccine employs the same messenger RNA (mRNA)technology used in the COVID-19 shots developed by Pfizer PFE.N with BioNTech 22UAy.DE, and by Moderna MRNA.O. It delivers tiny lipid particles containing mRNA instructions for cells to create replicas of so-called hemagglutinin proteins that appear on influenza virus surfaces.
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
"The idea here is to have a vaccine that will give people a baseline level of immune memory to diverse flu strains, so that there will be far less disease and death when the next flu pandemic occurs," study leader Scott Hensley of the Perelman School of Medicine at the University of Pennsylvania said in a statement.
Unlike standard flu vaccines that deliver one or two versions of hemagglutinin, the experimental vaccine includes 20 different types in the hope of getting the immune system to recognize any flu virus it might encounter in the future.
In lab experiments, vaccinated animals' immune systems recognized the hemagglutinin proteins and defended against 18 different strains of influenza A and two strains of influenza B. Antibody levels induced by the vaccine remained unchanged for at least four months, according to a report published in the journal Science.
The vaccine reduced signs of illness and protected from death even when the ferrets were exposed to a different type of flu not in the vaccine, the researchers said.
Moderna and Pfizer both have mRNA flu vaccines in late-stage human trials, and GSK GSK.L and partner CureVac 5CV.DE are testing an mRNA flu vaccine in an early-stage safety trial in humans. These vaccines are designed to defend against only four recently-circulating influenza strains but could theoretically be changed up each year.
The universal flu vaccine, if successful in human trials, would not necessarily prevent infection. The goal is to provide durable protection against severe disease and death, Hensley said.
Questions remain regarding how to judge efficacy and potential regulatory requirements for a vaccine against possible future viruses that are not currently circulating, Alyson Kelvin and Darryl Falzarano of the University of Saskatchewan, Canada, wrote in a commentary published with the study.
While the promising results with the new vaccine "suggest a protective capacity against all subtypes of influenza viruses, we cannot be sure until clinical trials in volunteers are done," Adolfo García-Sastrem, director of the Institute for Global Health and Emerging Pathogens at Mount Sinai Hospital in New York, said in a statement.
Reporting by Nancy Lapid; Editing by Christine Soares and Bill Berkrot
COVID-19 COVERAGE
CTVNews.ca Top Stories
Loblaw ends No Name price freeze, vows 'flat' pricing 'wherever possible'
Loblaw will not be extending its price freeze on No Name brand products, but vows to keep the yellow label product-pricing flat 'wherever possible.'

Family in remote northern Ont. reeling after daughter killed in fire, home destroyed
A family in the remote community of Peawanuck, Ont., is dealing not only with the death of their young daughter, but the loss of everything they owned in a Jan. 28 house fire.
opinion | Don Martin: Trudeau meets the moment – and ducks for cover
Based on Justin Trudeau's first-day fail in the House of Commons, 'meeting the moment' is destined to become the most laughable slogan since the elder Pierre Trudeau’s disastrous campaign rallying cry in 1972, which insisted 'the land is strong' just as the economy tanked.
Canada Post honours Chloe Cooley with stamp in time for Black History Month
A young Black woman who resisted her own enslavement in Queenston, Upper Canada, in the late 18th century is being honoured by Canada Post.
Canadian economy grew slightly in November, expected to slow further
The Canadian economy grew by 0.1 per cent in November as higher interest rates began to slow spending toward the end of the year.
Pakistan blames 'security lapse' for mosque blast; 100 dead
Pakistani authorities scrambled Tuesday to determine how a suicide bomber was able to carry out one of the country's deadliest militant attacks in years, unleashing an explosion in a crowded mosque inside a highly secured police compound in the city of Peshawar. The death toll from the blast climbed to 100.
'Laverne & Shirley' actor Cindy Williams dies at 75
Cindy Williams, who was among the most recognizable stars in America in the 1970s and 80s for her role as Shirley opposite Penny Marshall's Laverne on the beloved sitcom 'Laverne & Shirley,' has died, her family said Monday.
Federal agency targeting illegal wildlife trade through financial intelligence
Canada's financial intelligence agency is stepping up the fight against the illicit wildlife trade by taking aim at the criminals who reap big profits from the global racket.
Russian business offers cash bounties to destroy Western tanks in Ukraine
A Russian company said it will offer five million roubles (US$72,000) in cash to the first soldiers who destroy or capture western-made tanks in Ukraine, after the Kremlin vowed Russian forces would wipe out any Western tanks shipped to Ukraine.